Scrutinizer's Report
Pursuant to Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, please find enclosed herewith the results of remote e-voting and poll of the 66th Annual General Meeting of the Company held on August 30, 2017 along with Scrutinizer's Report. We hereby inform you that the members at the Annual General Meeting held on August 30, 2017, have appointed Messrs. Walker Chandiok & Co LLP, Chartered Accountants... Proceedings Of The 66Th Annual General Meeting Pfizer Limited
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed proceedings of the 66th Annual General Meeting of the Company held on August 30, 2017. We request you to kindly take the same on record. Analyst / Investor Meet Intimation
Pursuant to Regulation 30 of the Listing Regulations, attached herewith are the details of the meeting scheduled with an Analyst/Institutional Investor. Please note that the attached schedule is subject to change on account of exigencies on the part of the Analyst/Institutional Investor or the Company. This schedule shall also be displayed on the website of the Company - www.pfizerindia.com in compliance with the Regulation 46 of the Listing Regulations.... Alliance Foundation Trials launches PATINA phase 3 trial of CDK 4/6 inhibitor palbociclib to treat HR+, HER2+ metastatic breast cancer
The Alliance Foundation Trials, LLC (AFT), in conjunction with Pfizer and six international cancer research groups, announced the launch of PATINA a randomized, openlabel, phase 3 clinical study of the cyclindependent kinase Clarifies on news item
With reference to news in www.livemint.com dated August 23, 2017 quoting "India grants Pfizer patent for pneumonia vaccine", Pfizer Ltd has submitted to BSE a copy of Clarification is enclosed. India's patent to Pfizer will bar poor's access to pneumonia vaccine abroad
Pfizer's vaccine protects children and adults from 13 types of pneumococcal bacteria Clarification sought from Pfizer Ltd
The Exchange has sought clarification from Pfizer Ltd on August 23, 2017 with reference to news in www.indiainfoline.com dated August 23, 2017 quoting "India grants Pfizer patent for pneumonia vaccine"The reply is awaited. Analyst / Investor Meet Intimation
Pursuant to Regulation 30 of the Listing Regulations, attached herewith please find the details of the meeting scheduled with an Analyst/Institutional Investor: Please note that the attached schedule is subject to change on account of exigencies on the part of the Analyst/Institutional Investor or the Company. The said schedule shall also be displayed on the website of the Company - www.pfizerindia.com in compliance with the Regulation 46 of the Listing Regulations.... Analyst / Investor Meet Intimation
Dear Sirs, Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') Pursuant to Regulation 30 of the Listing Regulations, attached herewith please find details of the meetings scheduled with Analyst(s)/Institutional Investor(s). Please note that the attached schedule is subject to change on account of exigencies on the part of the Analyst/Institutional Investor or the Company.... Newspaper Publication
Pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements), Regulations, 2015 and the applicable provisions of the Companies Act, 2013, please find enclosed a copy of the newspaper advertisement inter-alia, informing about the Notice of the 66th Annual General Meeting of the Company along with the details of the remote evoting facility and book closure published in Business Standard (English) and Sakal (Marathi) on August 9, 2017....